Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trial
Abstract Intense intermittent fasting regimens safely reduce weight to a similar extent as caloric restriction. A previous trial reported low-frequency 26-week intermittent fasting reduced homeostatic model assessment of insulin resistance (HOMA-IR) without significant weight loss. During fasting, h...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Portfolio
2024-10-01
|
| Edice: | npj Metabolic Health and Disease |
| On-line přístup: | https://doi.org/10.1038/s44324-024-00025-2 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
